SIA
CDMO

Sit Investment Associates’s Avid Bioservices, Inc. Common Stock CDMO Stock Holding History

Sit Investment Associates’s Portfolio CDMO Stock Details CDMO Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2022
Q2 		– Sell
-18,900
Closed -$385K – 531
2022
Q1 		$385K Hold
18,900
– – 0.01% 427
2021
Q4 		$552K Buy
+18,900
New +$541K 0.01% 404

Other funds holding CDMO

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
AC
AltraVue Capital Bellevue, Washington $1.16B AUM 46.45% 1-Year Est. Return
RIM
Ranger Investment Management Dallas, Texas $1.38B AUM 24.55% 1-Year Est. Return
Jennison Associates
Jennison Associates New York $167B AUM 44.17% 1-Year Est. Return
Invesco
Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return
SCM
Snyder Capital Management San Francisco, California $5.16B AUM 26.72% 1-Year Est. Return
GCM
Geneva Capital Management Milwaukee, Wisconsin $4.36B AUM 17.81% 1-Year Est. Return

Sit Investment Associates's CDMO Position: Q2 2022 in Review

Sit Investment Associates sold out of Avid Bioservices, Inc. Common Stock (CDMO) in Q2 2022, closing a stake of 18,900 shares — an estimated $385K sold.

Sit Investment Associates first reported a position in CDMO in Q4 2021 and held it in 2 quarters. The position peaked at $552K in Q4 2021. 187 funds tracked by Wall St. Rank hold CDMO as of Q2 2022.

  • Sit Investment Associates reported no remaining Avid Bioservices, Inc. Common Stock position as of Q2 2022 after selling out during the quarter.
  • Sit Investment Associates sold 18,900 Avid Bioservices, Inc. Common Stock shares in Q2 2022, an estimated $385K.
  • Sit Investment Associates first reported a position in Avid Bioservices, Inc. Common Stock in Q4 2021 and held it in 2 quarters.
  • Sit Investment Associates's Avid Bioservices, Inc. Common Stock position peaked at $552K in Q4 2021.
  • 187 funds tracked by Wall St. Rank held Avid Bioservices, Inc. Common Stock as of Q2 2022.

Based on Sit Investment Associates's 13F filing for Q2 2022, filed 11 Aug 2022.